Archive for September, 2014

Blood test provides first objective diagnosis of depression in adults Video describes.

Tuesday, September 23rd, 2014

depression-shadow image

Diagnosing depression can be a difficult task, currently relying on patients reporting symptoms – something those suffering depression don’t always do – and doctors correctly interpreting them – which isn’t easy as the symptoms are non-specific. Now researchers have developed a blood test to diagnose depression in adults, providing the first objective, scientific diagnosis for the condition.

Earlier this year, a team from the University of Vienna revealed that measuring the levels of serotonin in the blood showed promise for potentially diagnosing depression through a blood test. And in 2012, Eva Redei, a professor of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine developed a blood test to diagnose depression in adolescents that involved looking at 26 genetic blood markers.

Building on that research, Redei and a team at Northwestern have developed a blood test to diagnose depression in adults. In the team’s study, they found that the levels of nine RNA blood markers in 32 patients, who were aged from 21 to 79 and had been independently diagnosed with depression after clinical interviews, were significantly different than levels in 32 non-depressed controls in the same age range.

After 18 weeks of therapy, both face-to-face and over the phone, changes in the levels of the markers allowed the researchers to differentiate between patients who had responded positively and were no longer depressed and those that remained depressed. The researchers say this is the first time a biological indicator has been used to indicate the success of cognitive behavioral therapy in adults suffering depression.

Additionally, examining the baseline levels of the nine markers in patients who subsequently recovered from depression after therapy allowed the researchers to identify a “fingerprint” from the blood test that would indicate which patients would benefit from cognitive behavioral therapy. This fingerprint didn’t appear in depressed patients who didn’t improve with the therapy.

Furthermore, the researchers found that the concentration levels of three of the nine RNA markers remained different in depressed patients and non-depressed controls, even if the depressed patients achieved remission after therapy. They say this suggests these three markers could indicate a vulnerability to depression.

“These three markers move us towards the ultimate goal of identifying predisposition to depression, even in the absence of a current depressive episode,” said Redei.

“Being aware of people who are more susceptible to recurring depression allows us to monitor them more closely,” added co-lead author David Mohr, a professor of preventive medicine and director of the Center for Behavioral Intervention Technologies at Feinberg. “They can consider a maintenance dose of antidepressants or continued psychotherapy to diminish the severity of a future episode or prolong the intervals between episodes.”

Redei now plans to test the results in a larger population and will also examine whether the test can be used to differentiate between major depression and bipolar depression.

In the video below, Redei gives an overview of the research, which is published in the journal Translational Psychiatry.

Published on Sep 22, 2014

Depression is a serious mental disorder, but now diagnosing and curing it might be easier than ever! Julian joins DNews today to discuss how there’s now a blood test that might be able to detect if someone is depressed!

Source: Northwestern University

Henry Sapiecha

rainbow line


Tuesday, September 23rd, 2014

Seven months, thousands of dead and a global crisis later, the murders occurred where it all began — in the remote forests of southeast Guinea, where superstition overwhelms education and whispers of Ebola stoke fear and sometimes violence.

The team of journalists and health workers arrived this week at the distant village of Womey to spread awareness of Ebola, the Guardian reported, where mention of lethal disease are met with denials and suspicion. Despite that, the initial meeting with villagers was promising.


“The meeting started off well,” one resident who was present at the talks told the Guardian. “The traditional chiefs welcomed the delegation with 10 kola nuts as a traditional greeting. It was afterwards that some youths came out and started stoning them. They dragged some of them away, and damaged their vehicles.”

Initially, Guinea officials claimed the aid workers and journalists had been taken captive and that distrustful residents had torn down bridges, prohibiting entry into the village. And then on Thursday night the news arrived. “The eight bodies were found in the village latrine,” government spokesman Damantang Albert Camara told Reuters. “Three of them had their throats slit.” He added in a separate interview: They were “killed in cold blood by the villagers.”

It was the most horrific act of Ebola-related violence to date in any of the affected countries. But it was far from the first display of local aggression. As the numbers of dead has surged, so has the violence: from an attack on a Guinea medical center in early April through the brandishing of knives in July to this week’s murders. The dangers under which health workers try to function appear to be heightening, as frightened locals continue to blame doctors for perpetuating the virus. And as Ebola spreads — 700 more cases were announced this week and the number of dead doubled this month — so may the acts of violence.


“We don’t want them in there at all,” Marcel Dambadounou, a Guinea village chief told the New York Times in July, referring to doctors and aid workers battling Ebola. “We don’t accept their presence at all. They are the transporters of the virus in these communities.” He added: “We are absolutely afraid, and that’s why we are avoiding contact with everybody — the whole world.”


The increase in violence marks a new dark chapter in the fight against Ebola, which has now killed at least 2,622 people, infected at least 5,335 people and pushed three West African nations into a state of emergency. Also troubling is the impact on aid workers of threats, harassment and violence. Some doctors and nurses, reported Inter Press Service, have stopped wearing their uniforms because they’re scared they will provoke attacks on the street.

“Health staff actually get [stones thrown at them] and it can become very violent,” Fabio Friscia, a United Nations coordinator for the Ebola awareness campaign, told GlobalPost. “…It is absolutely something we could expect. The population is being attacked by an absolutely new disease no one [in Western Africa] has ever seen before.”

During other outbreaks as well, some locals, driven by a combination of fright and superstition, attacked health workers. In a 2003 Ebola flare-up in Congo, volunteers with the Red Cross were chased by locals wielding clubs and knives, according to the Toronto Star. “You come roaring in with a team dressed in white suits and masks … you’ll have problems,” Ronald St. John, an infectious disease expert who has worked with the World Health Organization, told writer Scott Johnson.


Some say they have more confidence in tribal doctors, who prescribe remedies that do little to combat the pandemic. “This is very unusual, that we are not trusted,” Marc Poncin, emergency coordinator in Guinea for Doctors Without Borders, told the New York Times earlier in the summer. “We’re not stopping the epidemic.”

So in some villages such in Kolo Bengou, Guinea, youths equipped with slingshots and machetes guard local roads against aid workers, the Times reported. “We don’t want any visitors,” their leader said. “We don’t want any contact with anyone,” referring to Doctors Without Borders. “Wherever those people have passed, the communities have been hit by illness.”


Tuesday, September 23rd, 2014

The 10 Ebola treatment centers in West Africa are based on a design of three wards, which help separate patients suspected of having the disease from those with a confirmed diagnosis. Because there are not nearly enough such treatment centers, Liberia and the World Health Organization plan to set up much scaled-down versions, called community care centers, which will provide only rudimentary care. The community care centers would separate suspected and confirmed cases.

EbolaClinic structure image

1…TriagePatients with symptoms suggesting an Ebola infection are examined in a tent by medical workers wearing protective clothing.

2…Low-probability ward Patients who might not have Ebola wait here for hours or days until tests reveal whether they have the virus.

3…High-probability wardIf the medical staff suspects that someone has Ebola, the person is cared for in this tent until test results are in.

4…Ebola wardConfirmed cases are treated here. Because no cure exists, the medical staff can provide only supportive care, which increases the chance of survival

5…Morgue In some areas, as many as 75 percent of Ebola patients die. Bodies are stored temporar-ily in a morgue until medical workers can bury them


A…Dressing roomMedical staff entering the clinic put on protective equipment: dressing gown, apron, respirator, surgical cap, goggles, boots and two pairs of gloves. Clinic employ–ees work in twos, checking each other’s suits for tears or openings.

B…Undressing roomWorkers must undress very slowly and carefully to prevent infection, washing hands after removing each item of protective clothing. Some equipment can be reused after disinfection; other items are incinerated.

C…Patient exitRecovered patients take an antiseptic shower, put on clean clothes and step through decontamination basins before leaving the clinic. No longer infec–tious, they carry antibodies against the virus for as many as 10 years

D…Direct entryPatients with clear signs of an Ebola infection are taken straight to the Ebola ward, without going through triage.

E…Cemetery and incinerator Bodies are buried nearby but off site. Medical waste is burned a short distance away from the treatment center.

Henry Sapiecha

rainbow line


Tuesday, September 23rd, 2014


Res staff at Leer Hospital in South Sudan face a battle in the treatment of the fatal disease, kala azar

Henry Sapiecha

rainbow line


Thursday, September 18th, 2014

Cane toad poison ‘attacks prostate cancer cells’

Researchers find cane toad poison kills off prostate cancer cells while sparing healthy cells.

toad image

Henry Sapiecha

rainbow line


Thursday, September 18th, 2014

Published on Jul 18, 2013

Burzynski is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest and possibly the most convoluted and intriguing legal battle against the Food an Drug Administration in American history.

cannabis images www.druglinks (2)

His victorious battles with the United States government were centered on Dr. Burzynski’s belief in and commitment to his gene-targeted cancer medicines he discovered in the 1970′s called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of testing in 2011-barring the ability to raise the $25 million to fund the first one.

When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm-shifting, life-saving medical breakthrough. Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film that chose his treatment instead of surgery, chemotherapy or radiation — with full disclosure of original medical records to support their diagnosis and recovery.

One form of cancer — diffuse, intrinsic, childhood brainstem glioma has never before been cured in any experimental clinical trial in the history of medicine. Antineoplastons hold the first cures in history — dozens of them. Burzynski takes the audience through the treacherous, yet victorious, 14-year journey both Dr. Burzynski and his patients have had to endure in order to obtain FDA-approved clinical trials of Antineoplastons.

However, what was revealed a few years after Dr. Burzynski won his freedom, helps to paint a more coherent picture regarding the true motivation of the U.S. government’s relentless prosecution of Stanislaw Burzysnki.

Published on Jul 18, 2013

Henry Sapiecha


Thursday, September 18th, 2014

Published on May 14, 2014

A medical first — a woman with an incurable form of cancer has had all signs of living cancer cells eradicated from her body for at least 6 months. What’s more, it was accomplished in a single treatment. And the magic potion — was the measles virus.

Published on May 14, 2014

A medical first — a woman with an incurable form of cancer has had all signs of living cancer cells eradicated from her body for at least 6 months. What’s more, it was accomplished in a single treatment. And the magic potion — was the measles virus.

Henry Sapiecha

rainbow line

Seven Foods That Combat Cancer – Remember them.

Wednesday, September 10th, 2014

red bow on womans finger image

These are foods that are giants in defending your body against the ravages of the dreaded cancers.

They will also make you feel better & give you a better quality of life


curry bowl image

The right spice in your curry can block the tumour. University of Illinois pitted turmeric against 19 strains of the ultra-inducing bacterium that’s been linked to colon cancer. In each contest turmeric won hands down! It reduced the chronic inflammation caused by H.pylori. Other forms of turmeric are mustard on your sandwiches

Crazy Curry.
The right spice in your curry can block the tumour. University of Illinois pitted turmeric against 19 strains of the ultra-inducing bacterium thats been linked tocolon cancer. In each contest turmeric won hands down! It reduced the chronic inflammation caused by H.pylori. Other forms of turmeric are mustard on your sandwiches. – See more at:


trout fish on platter image

A study of 40,000 men determined that those that eat fish were 40 percent less likely to develop advanced prostate cancer. Its not just the omega 3 its the multitude of vitamins . That explains why supplements may not be as effective – stick to the real thing guys.


Lemon-on white background image

Freshly squeezed OJ has great health benefits but the cancer protection is missing – in the peel. People who consume citrus zest reduce the risk of skin cancer by 30 percent. Even lab rats live longer on the stuff.
It seems that all peel, lemon, orange all contain powerful compounds that stimulate the detoxifying enzyme.


green tea being poured image
Green tea has long been linked to helping prevent cancer – however white tea is twice as good at preventing colon cancer . White tea was 10 percent more effective at resisting colon polyp growths. It is also great for lack of side effects.


whey in bowl image

Ohio state university treated human prostrate cells with whey protein and measured its natural cancer-blocking compound called gluththinoe. They found that Glutathione levels rose by 64 percent.
One of the best sources of whey is yogurt, also add whey porridge


berries images www.foodpassions (1)

Berrys such as cranberries contain a treasure trove of tumour blocking compounds, including phenolic acids. These are effective in preventing colon and prostrate cancers. So hit the cranberry juice guys!


walnuts image

Researchers have found that when vitamin E is lined up against prostrate and lung cancer cells they discovered it was able to stop cancer in its tracks. They also help killing existing tumor cells.Found in a number of foods including walnuts

Hopefully the above will be of some use to you. So enjoy your foods & stay healthy & cancer free

Henry Sapiecha

rainbow line

Here we have rounded up the nutritional giants that fight the dreaded cancer, and have added ingenious ways to slip them into – See more at:
Here we have rounded up the nutritional giants that fight the dreaded cancer, and have added ingenious ways to slip them intoyour diet. While none of these are FDA approved they will make your body MUCH improved in the fight against cancer when you eat them. – See more at:
Here we have rounded up the nutritional giants that fight the dreaded cancer, and have added ingenious ways to slip them intoyour diet. While none of these are FDA approved they will make your body MUCH improved in the fight against cancer when you eat them. – See more at:
Here we have rounded up the nutritional giants that fight the dreaded cancer, and have added ingenious ways to slip them intoyour diet. While none of these are FDA approved they will make your body MUCH improved in the fight against cancer when you eat them. – See more at:
Here we have rounded up the nutritional giants that fight the dreaded cancer, and have added ingenious ways to slip them intoyour diet. While none of these are FDA approved they will make your body MUCH improved in the fight against cancer when you eat them. – See more at:


Wednesday, September 3rd, 2014

Don’t judge a book by its cover.

Same goes for food.

Fitting into the stereotypical if-it’s-good-for-me-it-can’t-taste-good category, bitter melon may look funny (like a warty cucumber) and may have a sharp taste, but it kills cancer cells.

It Really is Bitter–Sugar-Loving Cancer Doesn’t Like it.

bitter melon-juice-kill-cancer-cells-image

When bitter melon juice was introduced to pancreatic cancer cells, progression was halted and reversed. Mice were sixty percent less likely to develop the cancer after consuming it.

“BMJ [bitter melon juice] also inhibits proliferation, induces apoptosis and activates AMPK [a biomarker for cellular energy status] in vivo. Overall, BMJ exerts strong anticancer efficacy against human pancreatic carcinoma cells.”[1]

A 2013 study found similar response to head and neck cancer; when mice were fed bitter melon juice, tumors stopped growing.[2]

One Thing Leads to Another.

The way in which the researchers came up with the idea to test for bitter melon’s effectiveness against pancreatic cancer is interesting: previous studies had already established bitter melon as effective in the treatment of diabetes.

Diabetes in adults is caused by a combination of factors: the inability of the pancreas to produce enough insulin to moderate sugar levels in the blood and the decreased capacity of cells to absorb insulin (insulin resistance).

Because bitter melon juice interrupts glucose pathways in the blood, the levels are reduced. Additionally, compounds in the juice stimulated cell membranes to allow sugar intake.[3]

Commonly used in Chinese cooking and medicine, the juice of bitter melon (also known as bitter gourd or karela) contains an enzyme that inhibits the transportation of glucose (sugar), cutting off cancer cells’ food supply.


Because bitter melon juice influenced insulin production in the pancreas, scientists wondered if maybe there might be other implications for the pancreas.

They were right.

In traditional Chinese and Indian medicine, bitter melon has been used to heal wounds, treat fever, cough, skin conditions, colic, burns, and as an antiviral. In more modern applications, it aids in weight loss, reduces the incidence of kidney stones, boosts the immune sytem, and is a liver detoxifier.

It can be eaten raw (it is extremely bitter and should be mixed with other ingredients to ameliorate its strong flavor; salting it will reduce the bitterness, whether you choose to eat it raw or cook it), cooked, the juice extracted, or in a tincture. Of course, bitter melon is at its most nutritious when raw but that can be a challenge due to its strong bitter flavor.

Warning: in excess, bitter melon can cause abdominal pain and diarrhea.

So hold your breath, close your eyes, and swallow hard—this is one bitter pill that is worth swallowing.

Henry Sapiecha

Multi-purpose nanoparticle searches out cancer cells & delivers drugs to kill them.

Monday, September 1st, 2014

multi-purpose-nanoparticle image

A new multi-purpose nanoparticle has shown to possess both diagnostic and drug-delivering properties to treat cancer

Nanoparticles hold great potential as a way of both detecting cancer cells and delivering the drugs to treat them. One hurdle that has proven difficult to overcome is incorporating these properties into one multi-purpose device, as nanoparticles are generally engineered with either goal in mind. In what appears a promising development, researchers at the University of California Davis (UC Davis) Cancer Center have created a multi-tasking nanoparticle shown to be effective both in the diagnosis of a tumor and attacking its cells – a flexibility that could lead to new treatment options for cancer patients.

Nanoparticles are constructed using either inorganic or organic compounds, each with strengths of their own. Inorganic nanoparticles, such those made from gold, are effective in imaging and diagnostics. Particles made from organic compounds on the other hand, are biocompatible and provide a safe method of drug delivery, but without the great imaging potential.

The nanoparticles developed at UC Davis are built on a polymer made from a common organic compound called porphyrin and cholic acid, which is produced by the liver. The researchers then added cysteine to create a fluorescent carbon nanoparticle (CNP). This final ingredient is an amino acid serving to stop the particle prematurely releasing its payload as it moves through blood proteins and other barriers.

The team then put its new nanoparticle to the test, observing its effects across a range of tasks, both in vitro and in vivo. They found the particle was effective in delivering cancer-fighting drugs such as doxorubicin (commonly used in chemotherapy). Furthermore, applying light (known as photodynamic therapy) causes them to release reactive molecules called singlet oxygen that destroy tumor cells, while heating them with a laser (known as photothermal therapy) provided another way for the particles to destroy tumors.

One notable finding was that the release of a payload sped up as the particle was exposed to light. The researchers claim this ability to manipulate chemotherapy release rates from inside the tumor could help to minimize toxicity.

In relation to imaging and phototherapy, the nanoparticle remained in the body for extended periods and bonded with imaging agents. And because CNPs are drawn more to tumor tissue than normal tissue, it helps to improve contrast and light them up for MRI and PET scans.

“This is the first nanoparticle to perform so many different jobs,” says Yuanpei Li, research faculty member from the UC Davis Cancer Center. “From delivering chemo, photodynamic and photothermal therapies to enhancing diagnostic imaging, it’s the complete package.”

The team is now focusing on further pre-clinical studies, with a view to advancing to human trials if all goes to plan.

The research was published in the journal Nature Communications.

Source: UC Davis

Henry Sapiecha